Impact of Nanoparticles on Male Fertility: What Do We Really Know? A Systematic Review

The real impact of nanoparticles on male fertility is evaluated after a careful analysis of the available literature. The first part reviews animal models to understand the testicular biodistribution and biopersistence of nanoparticles, while the second part evaluates their in vitro and in vivo biotoxicity. Our main findings suggest that nanoparticles are generally able to reach the testicle in small quantities where they persist for several months, regardless of the route of exposure. However, there is not enough evidence that they can cross the blood-testis barrier. Of note, the majority of nanoparticles have low direct toxicity to the testis, but there are indications that some might act as endocrine disruptors. Overall, the impact on spermatogenesis in adults is generally weak and reversible, but exceptions exist and merit increased attention. Finally, we comment on several methodological or analytical biases which have led some studies to exaggerate the reprotoxicity of nanoparticles. In the future, rigorous clinical studies in tandem with mechanistic studies are needed to elucidate the real risk posed by nanoparticles on male fertility.

Automated summary

The real impact of nanoparticles on male fertility is evaluated based on a careful analysis of the available literature. The study finds that nanoparticles can reach the testicle and persist for several months, but there is not enough evidence of them crossing the blood-testis barrier. Most nanoparticles have low direct toxicity to the testis, but some may act as endocrine disruptors. The impact on spermatogenesis is generally weak and reversible in adults, but exceptions exist.